Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review.

To, Yat Hang; Gibbs, Peter; Tie, Jeanne; IJzerman, Maarten; Degeling, Koen

To, Yat Hang; Gibbs, Peter; Tie, Jeanne; IJzerman, Maarten; Degeling, Koen.

Afiliação

To YH; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. To.YatHang@mh.org.au.
Gibbs P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. To.YatHang@mh.org.au.
Tie J; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
IJzerman M; Department of Medical Oncology, Western Health, Melbourne, Australia.
Degeling K; Faculty of Medicine and Health Sciences, University of Melbourne, Melbourne, Australia.

Cost Eff Resour Alloc ; 21(1): 11, 2023 Jan 31.

Article em En | MEDLINE | ID: mdl-36721219

Palavras-chave

Cancer; Colon; Cost-effectiveness; Economic; Systematic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Systematic_reviews Idioma: En Revista: Cost Eff Resour Alloc Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google